Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature gene.
Geyer FH, Ritter A, Kinn-Gurzo S, Faehling T, Li J, Jarosch A, Ngo C, Vinca E, Aljakouch K, Orynbek A, Ohmura S, Kirchner T, Imle R, Romero-Pérez L, Díaz-Martín J, Bertram S, de Álava E, Henon C, Postel-Vilnay S, Banito A, Sill M, Versleijen-Jonkers Y, Mayer BFB, Ebinger M, Sparber-Sauer M, Stegmaier S, Baumhoer D, Hartmann W, Krijgsveld J, Horst D, Delattre O, Grohar PJ, Grünewald TGP, Cidre-Aranaz F.
Geyer FH, et al. Among authors: bertram s.
Cancer Commun (Lond). 2025 Jun;45(6):702-708. doi: 10.1002/cac2.70015. Epub 2025 Mar 15.
Cancer Commun (Lond). 2025.
PMID: 40088092
Free PMC article.
No abstract available.